BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28894311)

  • 1. Pharmacy Student Facilitation of Reporting of Adverse Drug Reactions in a Hospital.
    Wentzell J; Nguyen T; Bui S; MacDonald E
    Can J Hosp Pharm; 2017; 70(4):276-280. PubMed ID: 28894311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
    Sweis D; Wong IC
    Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital.
    Sullivan KM; Spooner LM
    Am J Health Syst Pharm; 2008 Jun; 65(12):1177-9. PubMed ID: 18541689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.
    Dweik RA; Yaya S; Stacey D; Kohen D
    Springerplus; 2016; 5():213. PubMed ID: 27026907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction reporting quality among different health professionals and the contribution of clinical pharmacists: A pilot study.
    Yan J; Xiong X; Shen J; Huang T
    J Clin Pharm Ther; 2022 Nov; 47(11):1768-1774. PubMed ID: 35781820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
    Barnes J; Butler R
    Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting.
    Hadi MA; Neoh CF; Zin RM; Elrggal ME; Cheema E
    Integr Pharm Res Pract; 2017; 6():91-98. PubMed ID: 29354555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning report: a forum for reporting adverse drug reactions.
    Sivaram CA; Johnson S; Tirmizi SN; Robertson V; Garcia D; Sorrells E
    Jt Comm J Qual Improv; 1996 Apr; 22(4):259-63. PubMed ID: 8743062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents.
    Baniasadi S; Habibi M; Haghgoo R; Karimi Gamishan M; Dabaghzadeh F; Farasatinasab M; Farsaei S; Gharekhani A; Kafi H; Karimzadeh I; Kharazmkia A; Najmeddin F; Nikvarz N; Oghazian MB; Rezaee H; Sadeghi K; Tafazzoli A; Shahsavari N; Fahimi F
    Iran J Pharm Res; 2014; 13(1):291-7. PubMed ID: 24734083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hospital and community pharmacists in pharmacovigilance.
    van Grootheest AC; de Jong-van den Berg LT
    Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.
    Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA
    Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting.
    Christensen ST; Søndergaard B; Honoré PH; Bjerrum OJ
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):399-404. PubMed ID: 21442686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
    Walji R; Boon H; Barnes J; Welsh S; Austin Z; Baker GR
    Int J Pharm Pract; 2011 Dec; 19(6):383-91. PubMed ID: 22060233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.